Antidepressant shows promise for sickle cell disease

02/20/2013 | MedicalDaily.com

The antidepressant tranylcypromine was able to stop a mechanism that leads to the development of sickle cell disease in laboratory tests, according to a study in the journal Nature Genetics. The drug allowed the production of fetal hemoglobin in tests of human cells and animals, researchers said.

View Full Article in:

MedicalDaily.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN